Skip to content

Terry K. Tullis

With more than a decade of experience in domestic and international strategic intellectual property portfolio management, Terry Tullis advises on patent, trademark, and copyright prosecution, enforcement, and licensing. Terry truly thrives in the continuous cycle of the evolution of the law, business, and rapid technological innovation.

p.p1 {margin: 0.0px 0.0px 8.0px 0.0px; font: 12.0px Arial}
p.p2 {margin: 0.0px 0.0px 12.0px 0.0px; font: 12.0px Arial}

Terry’s clients include individuals and large and small businesses involved in a wide range of technologies, including medical device, nanotechnology, and mechanical arts. Terry is known for his consistently good judgment and positive outcomes. Clients and colleagues alike appreciate Terry’s personal commitment to responsiveness and availability, which is reinforced by his proven skill in addressing both the simple and complicated problems of doing business today.

Fully invested in dispute resolution in the U.S. and abroad, Terry works tirelessly not only to ensure his clients obtain and leverage their valuable IP, but also protect their brand and innovated creativity around the world, particularly in Europe, China, and South Korea. He has provided both offensive and defensive advocacy in district court, before the Patent Trial and Appeal Board (PTAB), in interferences and inter partes review (IPRs), on appeal to the Federal Circuit, as well as in the prosecution, enforcement, and defense of client assets overseas.

Notably, Terry has worked extensively with orthopedic, spinal, cardiovascular, neurovascular, gynecological, and aesthetic technologies. He has been involved in the IP strategy, acquisitions, and investment rounds of Ulthera, Inc. (funding rounds and acquisition by Merz Pharmaceuticals), Sienna Biopharmaceuticals, Inc. (funding rounds and IPO), Endius, Inc. (acquired by Zimmer Holdings, Inc.), ev3 Inc. and ev3 Neurovascular (acquired by Covidien). Other medical device clients have included Sonoma Orthopedic Products, Inc., TranS1, Inc., and NovaLign Orthopaedics, Inc.

Prior to joining the firm, Terry was employed by NASA, Hewlett-Packard, IBM, and Johnson & Johnson. He worked in engineering design involving cardiovascular and diagnostic ultrasound systems, a DNA synthesizer for a biotechnology start-up, and various medical device projects with hospitals and companies. He also served as a management consultant engaged in strategic business consulting and project management for Fortune 500 companies and government clients, and as a marketing manager for a medical device company.

Working as a business professional before the law made Terry a far more effective and credible lawyer to the businesses and entrepreneurs he represents today. Much of his advice involves strategic decisions that are grounded in business and supported by the law. Because Terry understands, from first-hand experience, what drives business development, he is able to apply the law in a far more practical manner when it comes to his client’s immediate and long-term commercial objectives.

University of California – Los Angeles – School of Law (UCLA), J.D.
University of California – Berkeley – Haas School of Business (CAL), M.B.A., Master of Business Administration
Stanford University, M.S., Biomechanical Engineering
Stanford University, B.S., Mechanical Engineering and Product Design, Tau Beta Pi Engineering Honor Society
State Bar of California
U.S. Court of Appeals for the Federal Circuit
U.S. District Court – Central District of California
U.S. Patent and Trademark Office

Aesthetic & Cosmetic Biotechnology

Chemical, Industrial & Materials

Building Construction

Building Products & Materials

Construction & Home Improvement

Cosmetics & Personal Care Products

Machine Shops

Pharmaceutical Chemistry

Consumer Products & Services

Aesthetics & Personal Care Products

Electrical, Semiconductor & Computer Technology

Healthcare Information Technology

Medical Devices & Procedures

Ablation Technology

Aesthetics & Implants


Annulus & Nucleus Repair


Cardiac Rhythm Management


Catheters & Probes

Dermatology & Aesthetics

Drug Eluting & Drug Delivery Devices

Ear, Nose, & Throat

Embolic Coils

Embolic Protection & Clot Retrieving

Hypertension Management Devices



Ischemic Stroke

Left Atrial Appendage (LAA) Occlusion



Patent Foramen Ovale Closure

Prosthetics & Orthotics

Spinal Fusion


Surgical Equipment


Assignments and Licenses
Brand Portfolio Management
Brand Search
Design Patents
Due Diligence
Global Portfolio Management
Infringement Risk 
Inter Partes Review (IPR)
International Trademarks
IP Strategy
IP Transactions and Agreements
Opinions Counseling
Patent Strategy & Prosecution
Tech Transactions
Trademark & Brand Protection
Trademark and Brand Protection Litigation
Trademark Enforcement
Trademark Registration
TTAB Proceedings
U.S. Patent Prosecution

Recognized by The Legal 500 “United States” for Patent Licensing (2019-2023) and Patent Prosecution (2022-2023)

Winner of the Benjamin Aaron Award for the best piece of published legal scholarship in any UCLA law journal for his published comment “Application of the Government License Defense to Federally Funded Nanotechnology Research: The Case for a Limited Patent Compulsory Licensing Regime,” 53 UCLA L. Rev. 279 (2005).

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal